Literature DB >> 2491462

Review article: a role for gastrointestinal prokinetic agents in the treatment of reflux oesophagitis?

M Verlinden1.   

Abstract

Gastro-oesophageal reflux disease may result from a host of factors. Medical therapy has largely been aimed at neutralizing acid or decreasing acid production but improvement of upper-gastrointestinal motility may prove to be a valuable treatment modality as well. This paper reviews the current state of knowledge of the pathogenesis of reflux disease and concentrates upon promotility treatment with domperidone, metoclopramide and cisapride.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2491462     DOI： 10.1111/j.1365-2036.1989.tb00197.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


  6 in total

Review 1.  Gastro-Oesophageal reflux in the elderly: role of drug therapy in management.

Authors:  A B Thomson
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

2.  Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.

Authors:  W Inauen; C Emde; B Weber; D Armstrong; H U Bettschen; T Huber; U Scheurer; A L Blum; F Halter; H S Merki
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

3.  Cisapride in neurologically impaired children with chronic constipation.

Authors:  A Staiano; E Del Giudice; D Simeone; E Miele; A Marino
Journal:  Dig Dis Sci       Date:  1996-05       Impact factor: 3.199

4.  Healing and prevention of relapse of reflux oesophagitis by cisapride.

Authors:  J Toussaint; A Gossuin; M Deruyttere; F Hublé; G Devis
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

5.  Effect of cisapride on relapse of esophagitis. A multinational, placebo-controlled trial in patients healed with an antisecretory drug. The Italian Eurocis Trialists.

Authors:  A L Blum; B Adami; M H Bouzo; G Brandstätter; I Fumagalli; J P Galmiche; H Hebbeln; E Hentschel; W Hüttemann; E SChütz
Journal:  Dig Dis Sci       Date:  1993-03       Impact factor: 3.199

Review 6.  Pharmacological management of gastro-oesophageal reflux disease.

Authors:  E C Klinkenberg-Knol; H P Festen; S G Meuwissen
Journal:  Drugs       Date:  1995-05       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.